I think everybody on this panel agrees with you when you said that we need to get away from the antiquated production model, which the egg is.
Diana DeGette
The Public Record
Diana Louise DeGette is a U.S. Representative for Colorado's 1st congressional district, having served since January 3, 1997. A member of the Democratic Party, she has been a prominent advocate for health care reform and women's rights throughout her tenure in Congress. DeGette has played a significant role in various legislative efforts, particularly in expanding access to health care services. Her work has garnered support from organizations such as the National Association of Community Health Centers.
As an example, my home State of Colorado set two records, not good records, this year.
The importance of a strong public health infrastructure cannot be overstated.
This year, again, we are experiencing a severe flu season caused by the H3N2.
I have just received a letter from our colleague, Diana DeGette, with a statement from the City and County of Denver...
Well, good news. Four courts have already said that your Department can't stop them from getting abortions.
This seems like an unacceptable intrusion into the attorney-client relationship to me.
These are cruel inflictions from an administration who claims to be addressing the opioid crisis.
As I said in my opening statement, my colleague, Tom Reed, and I have been looking into insulin prices, and I think that our investigation, the facts we've learned, have broad implications from the consolidation issues here today.
Excessive consolidation leaves consumers with few choices, which not only limits their care options but also has the potential to raise prices.
It is clear that the delivery of care is changing, and not always to the benefit of patients and payers.
I have got strong reservations about undermining or loosening the DQSA's prescription requirement in any way, given the consideration that any move in that direction could have an impact on patient safety.
As Mr. Green mentioned, he and Congressman Griffith and I worked really hard after that terrible tragedy of the New England Compounding Center to come up with our Compounding Quality Act, which was subsequently folded into the Drug Quality…
If you think that there's more authority this committee needs to give to the agency to bolster that, and if you think there's more resources or stability of resources to do this hiring, let us know, because we--this is one of these…
Thank you so much, Mr. Chairman. As you know, food safety is not a new issue for this committee.
We are prohibited from using Brownfields money for Superfund cleanup, right?
But I think the profit has gotten way out of control in many cases. I want to make sure the potential for profit is truly incentivizing innovation, not just lining investors' pockets.





